SCL — Stepan Company

Stepan Company Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Adjusted Net Income: $10.9 million ($0.48 per diluted share), down 54% from $23.7 million ($1.03 per diluted share) in Q3 2024.
• Adjusted EBITDA: $56.2 million, a 6% increase year-over-year, driven by strong performance in Specialty Products.
• Sales Volumes: Total company sales volumes grew by 1%, with Polymers up 8% and NCT product line up 26%, while Surfactants volume declined 2%.
• Free Cash Flow: Positive at $40.2 million, significantly improved by reduced working capital and disciplined capital spending.
• Dividends: $8.7 million paid in dividends, with a 2.6% increase in the quarterly cash dividend to $0.395 per share.

2. Strategic Updates and Business Highlights

• Specialty Products: Adjusted EBITDA increased by 113%, attributed to favorable order timing in the pharmaceutical segment.
• Polymers: Continued growth in North America Rigid Polyol and commodity Phthalic Anhydride, despite a 4% decrease in net sales due to lower selling prices.
• Surfactants: Experienced a 10% increase in net sales, but adjusted EBITDA declined by 14% due to higher raw material costs and start-up expenses at the new Pasadena facility.
• Operational Improvements: The Pasadena facility is now operational, with expectations for full contribution by 2026. The company is also focusing on customer acquisition and end-market diversification.

3. Forward Guidance and Outlook

• Margin Recovery: Management aims to recover margins affected by oleochemical price increases by 2026, with ongoing price adjustments.
• Market Conditions: Anticipation of improved demand in construction and potential interest rate reductions could stimulate activity in the Polymers segment.
• Free Cash Flow: The company remains optimistic about generating positive free cash flow for the full year 2025.

4. Bad News, Challenges, or Points of Concern

• Declining Adjusted Net Income: The significant drop in adjusted net income is attributed to a higher effective tax rate, increased interest expenses, and higher depreciation costs from the Pasadena facility start-up.
• Surfactant Margin Pressures: Continued inflation in oleochemical raw materials and lower demand in global commodity consumer products are impacting margins.
• European Market Uncertainties: Ongoing macroeconomic challenges in Europe are affecting the Polymers segment, particularly in construction activity.

5. Notable Q&A Insights

• Oleochemical Cost Recovery: Management indicated that while prices are coming down, full recovery of margins in the Surfactants segment may take longer than anticipated.
• Long-term Margin Goals: There is optimism that Surfactants could return to double-digit operating margins in the future, contingent on growth in functional markets and improved product mix.
• Pent-up Demand in Polymers: There is belief in pent-up demand for commercial roofing and insulation, which could be stimulated by lower interest rates.
• Asset Optimization: The company is evaluating opportunities for optimizing its asset base, including the sale of the Philippines site and potential future divestments.

This summary reflects a balanced view of Stepan Company's Q3 2025 performance, highlighting both achievements and challenges faced in the current market environment.